Kodiak Sciences

About:

Kodiak is designing and developing novel therapies for the treatment of retinal disease.

Website: http://kodiak.com/

Top Investors: Perceptive Advisors, ArrowMark Partners, Rivas Capital

Description:

Kodiak Sciences is designing and developing novel therapies for the treatment of retinal disease. As a rapidly growing biopharmaceutical company, we are working every day to build value for the benefit of our community of patients, physicians, employees, families, and vendors. We want to have real impact, and we take a long term view. We are committed to ethics and excellence in everything we do. We are looking to hire top talent comfortable with ownership and accountability of exciting programs while collaborating effectively with colleagues inside and outside the company.

Total Funding Amount:

$1.03B

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)kodiak.com

Founders:

Stephen Charles, Victor Perlroth

Number of Employees:

101-250

Last Funding Date:

2020-11-17

IPO Status:

Public

© 2025 bioDAO.ai